BioCentury
ARTICLE | Financial News

Advent Venture Partners financial update

November 3, 2014 8:00 AM UTC

The firm's active portfolio includes antifungal company F2G Ltd. (Manchester, U.K.), diagnostics play Biocartis S.A.(Lausanne, Switzerland), and growth hormone play Versartis Inc. (NASDAQ:VSAR, Red...